about
An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood.Group A streptococcal endophthalmitis complicating a sore throat in a 2-year-old child.Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom?Acute angle closure glaucoma: relative failure of YAG iridotomy in affected eyes and factors influencing outcomeParaneoplastic retinopathy in association with large cell neuroendocrine bronchial carcinoma.A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial).Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors.Branch retinal artery occlusion: a case complicating acute rheumatic fever and dental abscess.Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.Reconsidering treatment options in childhood uveitis.Uveitis associated with parvovirus infection.Intermediate uveitis and sarcoidosis.Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program.Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience.Uveitis: basic concepts and differential diagnosis.Inflammatory lesions of the orbit: a single paediatric rheumatology centre experience.Tubulointerstitial nephritis, uveitis, hearing loss and vestibular failure: TINU-atypical Cogan's overlap syndrome.Visual loss associated with pediatric uveitis in english primary and referral centers.Inflammatory lesions of the orbit: a single paediatric rheumatology centre experiencePossession of theHLA-DRB1*1501Allele and Visual Outcome in Idiopathic Intermediate UveitisOrbital varices diagnosed as episcleritis in a child with juvenile idiopathic arthritisBlindness following a diabetic foot infection: a variant to the 'eye-foot syndrome'?The ocular and systemic prognosis of patients presenting with sarcoid uveitisThe British Ophthalmological Surveillance Unit: The study of uncommon ophthalmic disorders made easierAntibodies against retinal S-antigen in patients with juvenile chronic arthritis-associated uveitisSystemic morbidity in patients with isolated Idiopathic retinal vasculitisSoluble intercellular adhesion molecule-l (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitisThe efficacy of systemic corticosteroids in sight-threatening retinal vasculitisAnti-endothelial cell antibodies in retinal vasculitisAdalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
P50
Q34500967-853F9F7A-40AE-477D-9BB1-95A89936F44CQ35467308-E2316C1E-5DDE-435B-BC89-BD50074F57AEQ35593455-5B3262C4-2284-489F-82D9-DC8FA061D2D6Q36722491-5ED07D62-E6F5-4B37-9CFC-F9AC31EC4DE1Q37313339-54ED874B-26FE-4AB7-9425-4F9C7090B881Q37479820-3CB5A8C6-9EF4-49CE-AE97-2C40FD44B430Q37995987-9BFE1FC4-0A76-4B80-B38A-16FF32CD8F7DQ38109932-95E13899-0DD7-4FDE-8D7A-BA594C660CC4Q40616357-9CF77B61-B30E-4C8E-B240-4BDA8B83E6F4Q42226901-205D5350-F407-4440-A21B-AC7ABFB04647Q42840715-AF7399D1-22BB-45FB-86F4-668AC4B939A1Q43094178-0E053AC4-03A8-4F17-9FB4-BCA22588C23AQ43748459-EA115B80-C45F-4FA2-8498-D193D8D56B89Q44466477-519BF219-8B3E-46BC-9CD6-82B334E73886Q45325652-956CC90F-1346-4C44-A60A-18A652C80CB8Q46860627-D4DFACCB-FCB3-47F3-A43F-436873BF7C0DQ47103241-F1DA8952-449D-471D-9718-4FCF96840E4CQ50431896-1E085852-59E7-40C1-ADB9-D4F20D3CA1BBQ52950831-12E9FE4F-6F86-457A-92B6-319123034893Q57522062-0FA11491-FEAD-4189-A3F2-BF558F5E364AQ59938707-1C821F2D-1ED1-4F41-BA63-39F592DC2263Q61054135-4BB85D44-9729-4CA1-9A1A-932F5734A5C5Q61054136-0569075C-BE20-498B-9EAC-1277C0D2CE10Q61054138-FB7F76E1-AADF-4982-9C46-1D22B27F0434Q61054140-EA600A16-2E24-4A07-B054-801A09DBD350Q61054141-CEAF8216-8B39-486A-AC13-6CC9D9E3A363Q61054142-8C734277-1CD9-4F6C-A6B8-C99C5F25B9E8Q61054143-BAFE3FFC-F534-4D5F-8A3F-6BEC7492E532Q61054144-A5FD0019-B1B1-463E-9573-D6F6411D8707Q61054145-229C2B75-BB72-4585-A905-46430B97AC16Q64092580-0D710A5C-3F50-4B21-9EF5-19E517B81C48
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Clive Edelsten
@ast
Clive Edelsten
@en
Clive Edelsten
@es
Clive Edelsten
@nl
type
label
Clive Edelsten
@ast
Clive Edelsten
@en
Clive Edelsten
@es
Clive Edelsten
@nl
prefLabel
Clive Edelsten
@ast
Clive Edelsten
@en
Clive Edelsten
@es
Clive Edelsten
@nl
P106
P21
P31
P496
0000-0002-5845-3956